Simplex Trading, LLC Kempharm, Inc Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	N/A	-52,817 Reduced 76.33%	16,380 $80,000
Q2 2024 Jul 25, 2024	BUY	N/A	33,731 Added 95.11%	69,197 $341,000
Q1 2024 Apr 25, 2024	BUY	N/A	30,235 Added 578.0%	35,466 $175,000
Q4 2023 Feb 02, 2024	BUY	N/A	5,231 New	5,231 $34,000
Q2 2023 Aug 04, 2023	BUY	$4.94 - $6.29 $62,708 - $79,845	12,694 New	12,694 $62,000
Q4 2022 Feb 02, 2023	SELL	$4.12 - $5.62 $142,098 - $193,833	-34,490 Reduced 69.55%	15,103 $69,000
Q3 2022 Nov 04, 2022	BUY	$4.5 - $6.85 $77,899 - $118,580	17,311 Added 53.62%	49,593 $309,000
Q2 2022 Aug 03, 2022	SELL	$4.02 - $5.21 $15,529 - $20,126	-3,863 Reduced 10.69%	32,282 $143,000
Q1 2022 May 02, 2022	SELL	$5.0 - $9.26 $21,930 - $40,614	-4,386 Reduced 10.82%	36,145 $181,000
Q3 2021 Oct 28, 2021	BUY	$8.72 - $13.31 $20,971 - $32,010	2,405 Added 6.31%	40,531 $539,000
Q2 2021 Aug 12, 2021	BUY	$8.52 - $15.47 $324,833 - $589,809	38,126 New	38,126 $488,000

112

29.9M

418K

43K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.